NPB

Northpointe Bancshares, Inc. · NYSE

News

4 latest

Zacks Investment Research

Northpointe Bancshares, Inc. (NPB) Q3 Earnings and Revenues Lag Estimates

Northpointe Bancshares reported Q3 earnings of $0.39 per share, missing the consensus estimate of $0.60 per share by 35%. Revenues of $55.92 million also fell short of expectations by 12.72%. The company has failed to beat consensus EPS estimates for four consecutive quarters and received a Zacks Rank #4 (Sell) rating, indicating expected underperformance relative to the market.

Zacks Investment Research

Northpointe Bancshares, Inc. (NPB) Reports Q3 Earnings: What Key Metrics Have to Say

Northpointe Bancshares reported Q3 2026 revenue of $55.92 million, down 13.1% year-over-year and missing consensus estimates by 12.72%. EPS came in at $0.39, significantly below the $0.60 consensus estimate.

Zacks Investment Research

Banner (BANR) Reports Next Week: Wall Street Expects Earnings Growth

Banner (BANR) is expected to report Q3 2026 earnings of $1.54 per share with 7.1% revenue growth, but a negative Earnings ESP of -2.02% combined with a Zacks Rank #3 makes an earnings beat unlikely. Similarly, Northpointe Bancshares (NPB) faces headwinds with a -2.52% Earnings ESP and Zacks Rank #4, suggesting both regional banks may struggle to beat consensus estimates.

Zacks Investment Research

Northpointe Bancshares, Inc. (NPB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Northpointe Bancshares is expected to report Q3 2026 earnings of $0.60 per share (up 5.3% YoY) with revenues of $64.07 million (down 0.5% YoY) on October 20. However, with a negative Earnings ESP of -2.52% and a Zacks Rank #4 (Sell), the stock is not considered a compelling earnings-beat candidate. The company has missed consensus estimates in 3 of the last 4 quarters.

Headlines link to the publisher. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.